Tuesday March 26, 2019

Marijuana Considered Safe to Cure Epilepsy in Kids

While the study's authors said the results were significant, they stressed that the purpose of this study was about safety not efficacy

0
//
Marijuana
Marijuana safe to treat epilepsy in kids: Study. Pixabay

Consuming a marijuana-based drug may be safe in treating children with severe epilepsy, results of a clinical trial has showed.

Following treatment with cannabidiol — a non-psychoactive compound found in marijuana — about one in five children were described as much or very much improved from their baseline, while around half reported none, or a very slight improvement, Xinhua news agency reported.

While the trial was conducted on a small group of children with severe epilepsy, it showed that the drug had a manageable side effect profile, but only showed extensive symptom relief for a brief number of patients.

The trial “involved the sickest children with epilepsy — children who are having seizures many times per day, who have been recently hospitalized for their epilepsy, and have failed on average about nine anti-epilepsy drugs before,” said lead author John Lawson, paediatric neurologist at Sydney’s Children’s Hospital.

Here is another article on healing properties of Marijuana by CBD Oil Room

“The main aim of the study was about safety. We found that there were a few safety concerns but overall those safety issues were very manageable and the drug overall was very safe for the majority,” he added.

Marijuana
Marijuana leaves. Pixabay

The study was published in the Medical Journal of Australia.

Although legally cannabis must be prescribed by a doctor, recent reports of cannabis derivatives being successful in treating children with epilepsy have led to a number of parents of sick children sourcing their own medical marijuana.

While the study’s authors said the results were significant, they stressed that the purpose of this study was about safety not efficacy.

Also Read: Oldest Known Rocks Evolved on Earth Are Result of Asteroids, Research Reveals

The US Food and Drug Administration had recently approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy — Lennox-Gastaut syndrome and Dravet syndrome — in patients two years of age and older. (IANS)

Next Story

Nose of Kids Hold Clues to Serious Lung Infections

Experts say this breaks with traditional thinking that symptoms predict whether either a virus or bacteria is causing the illness and could impact a decision of whether or not to use antibiotics

0
People pass by an installation of an artificial model of lungs to illustrate the effect of air pollution outside a hospital in New Delhi, India, Nov. 5, 2018.

Tiny organisms in a child’s nose could offer clues to improving the diagnosis and treatment of severe lung infections, a new study suggests.

The study found that the composition of the microbiome — bacteria and viruses found in vast numbers in the body — was altered in the noses of children with respiratory infections, compared with his healthy peers.

This difference predicted how much time children had to spend in hospital and helped spot those likely to recover naturally, potentially reducing the need for antibiotics, said researchers from the University of Edinburgh.

“Our findings show, for the first time, the total microbial community in the respiratory tract — rather than a single virus or a bacteria — is a vital indicator of respiratory health. This could impact how doctors diagnose LRTIs and use precious antibiotics to fight infections,” said lead author Debby Bogaert, Professor at the varsity.

Lower respiratory tract infections (LRTIs), including pneumonia and bronchiolitis, are a leading cause of death. Symptoms include, shortness of breath, weakness and fever.

Coal Miners
Former coal miner Wade Pauley, who has Black Lung disease after working 33 years underground in mines, stands for a chest x-ray at United Medical Services in Pikeville, Kentucky, U.S., May 22, 2018. (VOA)

It was found that the microbiome in the back of the nose and throat was related to that seen in the lungs, making it easier to understand and diagnose infections.

For the study, published in The Lancet Respiratory Medicine, the researchers studied more than 150 children under the age of six, hospitalised with LRTI. They compared them with 300 healthy children.

Children with LRTI had a different microbiome profile — including the types and amounts of individual viral and bacterial organisms — compared with the healthy children.

Also Read- Inactive Ingredients in Medicines May Cause Allergy: Study

These profiles could identify 92 per cent of children as being healthy or ill when combined with factors like the child’s age. This was true no matter what symptoms the child had.

Experts say this breaks with traditional thinking that symptoms predict whether either a virus or bacteria is causing the illness and could impact a decision of whether or not to use antibiotics. (IANS)